Transient growth factor delivery sustains regenerated axons after spinal cord injury.
about
Oligodendrocyte-myelin glycoprotein and Nogo negatively regulate activity-dependent synaptic plasticityGene delivery strategies to promote spinal cord repairPeripherally-derived BDNF promotes regeneration of ascending sensory neurons after spinal cord injuryTGF-alpha increases astrocyte invasion and promotes axonal growth into the lesion following spinal cord injury in mice.Biomaterial design strategies for the treatment of spinal cord injuries.Chondroitinase activity can be transduced by a lentiviral vector in vitro and in vivo.Multifunctional, multichannel bridges that deliver neurotrophin encoding lentivirus for regeneration following spinal cord injuryMotor axonal regeneration after partial and complete spinal cord transectionDependence of regenerated sensory axons on continuous neurotrophin-3 deliveryCurrent advances in using neurotrophic factors to treat neurodegenerative disordersLong-term reversal of cholinergic neuronal decline in aged non-human primates by lentiviral NGF gene deliveryTargeting Motor End Plates for Delivery of Adenoviruses: An Approach to Maximize Uptake and Transduction of Spinal Cord Motor Neurons.Relationship between scaffold channel diameter and number of regenerating axons in the transected rat spinal cord.Long-term viral brain-derived neurotrophic factor delivery promotes spasticity in rats with a cervical spinal cord hemisection.The application of viral vectors to enhance regeneration after peripheral nerve repair.Central nervous system delivery of large molecules: challenges and new frontiers for intrathecally administered therapeutics.Construction of pathways to promote axon growth within the adult central nervous system.Gene therapy approaches to enhancing plasticity and regeneration after spinal cord injury.Neurotrophic factors in combinatorial approaches for spinal cord regenerationClinical and neurobiological advances in promoting regeneration of the ventral root avulsion lesion.Cell biology of spinal cord injury and repair.A novel inducible tyrosine kinase receptor to regulate signal transduction and neurite outgrowth.Neurotrophins: potential therapeutic tools for the treatment of spinal cord injury.The hemopexin domain of matrix metalloproteinase-9 activates cell signaling and promotes migration of schwann cells by binding to low-density lipoprotein receptor-related protein.Noninvasive bioluminescence imaging of olfactory ensheathing glia and schwann cells following transplantation into the lesioned rat spinal cord.Transcription factor SCIRR69 involved in the activation of brain-derived neurotrophic factor gene promoter II in mechanically injured neurons.Gastrocnemius-derived BDNF promotes motor function recovery in spinal cord transected rats.Influence of Genetically Modified Human Umbilical Cord Blood Mononuclear Cells on the Expression of Schwann Cell Molecular Determinants in Spinal Cord Injury.Immune-evasive gene switch enables regulated delivery of chondroitinase after spinal cord injuryRegenerative Strategies for the Central Nervous System
P2860
Q24619952-A6EB40E5-20C5-4A7B-9634-7FCA7FE7177AQ26825131-EDD5D5AF-33AB-4CC9-BDBE-56E968615FE3Q27301855-8275191A-06DB-47AA-90E4-FB5169608848Q33956900-D4775E63-162D-4942-88C2-AF140A04A482Q34076638-9E9BD863-1942-46BD-A23B-30958B43A9F3Q35112769-BAD714CA-3E14-4F7C-B85C-6CE3E8EB5E05Q35613352-619FCAF3-A9E9-4D91-9F43-8720B79A4B99Q36124800-D21128A2-5446-4570-9F08-E428AFCE4428Q36442991-0BE8E9F7-421A-4B60-8C4A-5286C255594AQ36525034-5BBBE10E-8CB9-404C-9CCD-5AE13566EE9EQ37076735-FE799FD2-B231-47AC-875B-F7F10B41D0A9Q37251346-BEC60D9E-5A01-4C1F-B4F4-CF076C46130EQ37318216-1D64455A-EF6D-401E-9FB1-63158633F42AQ37322072-E0B93D85-1AAC-40AE-8371-3AA5E4BE27A6Q37350126-0C8F57ED-0DBB-40DA-B607-F28ADBAE78B5Q37702246-4D5319D1-14EE-4EA7-BBA4-CC9A937A905BQ37765694-98FA669A-34CA-4047-AF0F-90613CDDB948Q37833693-4D81D2AB-2534-4C77-9D52-400BC40642B7Q38004819-4875A3C7-8AF1-4EC3-9E06-F89B571D6BDEQ38594655-63422102-7E3F-4683-A0DE-FCD0D9B88003Q39454081-CA059730-6C86-4CDD-85D0-50D4C50728E1Q40020762-1CC21155-DCCE-449A-B803-379BE6ACACD4Q40125092-7935FFB1-9B22-4FD4-87DF-89F55E1E01ABQ41912504-CEC83961-58D5-4EAC-885E-E74A362235DEQ47980734-ED6C455A-52AB-42A1-BBE8-6237609A0579Q48031073-1AF15CF2-D0F3-41C3-91AB-0D8D5D52EF30Q48560891-7F831BCC-09E5-45E0-B1F0-A76C29230962Q55073386-57CF054A-0B80-4E96-97DA-F64FCD5FDFF8Q56776244-D2966753-8118-4580-88C9-57AEE75767D9Q57460363-C182EF4D-1645-4AA1-92EF-A6E1CDCB513F
P2860
Transient growth factor delivery sustains regenerated axons after spinal cord injury.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Transient growth factor delivery sustains regenerated axons after spinal cord injury.
@en
Transient growth factor delivery sustains regenerated axons after spinal cord injury.
@nl
type
label
Transient growth factor delivery sustains regenerated axons after spinal cord injury.
@en
Transient growth factor delivery sustains regenerated axons after spinal cord injury.
@nl
prefLabel
Transient growth factor delivery sustains regenerated axons after spinal cord injury.
@en
Transient growth factor delivery sustains regenerated axons after spinal cord injury.
@nl
P1476
Transient growth factor delivery sustains regenerated axons after spinal cord injury.
@en
P2093
Mark H Tuszynski
P304
10535-10545
P356
10.1523/JNEUROSCI.1903-07.2007
P407
P50
P577
2007-09-01T00:00:00Z